Crossmark

Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy

Crossref DOI link: https://doi.org/10.1186/s12885-022-10152-y

Published Online: 2022-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hung, Chuan-Jen

Kang, Bor-Hwang

Chang, Keng-Ming

Kang, Ying-Ying

Yin, Chun-Hao

Lee, Ching-Chih https://orcid.org/0000-0001-6249-1798
Funding

Funding for this research was provided by:

Kaohsiung Veterans General Hospital (KSVGH 110-139)
License Information

Text and Data Mining valid from 2022-10-21

Version of Record valid from 2022-10-21
More Information

Article History

Received: 4 March 2022

Accepted: 5 October 2022

First Online: 21 October 2022

Declarations

:

: The Ethics Committee of the Institutional Review Board of Kaohsiung Veterans General Hospital approved the study protocol (KSVGH22-CT1-03). Because we did not use human participants or personally identifiable records in our analysis, the Institutional Review Board of Kaohsiung Veterans General Hospital decided to waive the informed consent for this study.

: Not applicable.

: The authors declared they have no competing interests.

Document is current

Any future updates will be listed below